ARCHIVES

FDA Committee to Discuss Policy On Combinations

This article is from The Cancer Letter archive.

Vol. 03 No. 01 | January 7, 1977

Download PDF Visit The Full Archive

Related Articles

Perifosine Fails Primary Endpoint, Zentaris CEO Explores Options

April 27, 2012

NIH reauthorization to be topic of July 19 hearing.

July 15, 2005

“Proof Of Concept” Shown In Early Trial Of PKC-412

December 27, 2002

Intermittent Androgen Deprivation Therapy Not Equal to Continuous Treatment, Study Finds

April 26, 2013

CCI Will Tackle Reimbursement Issue

May 16, 1980

Preliminary estimates based on NLST results: Year Of Life Saved Could Cost $38,000

July 1, 2011